FHL Management Team
-
Alex Yang, JD, LLM
Chief Executive Officer & Chair of the Board
-
Anthony Lam, CFA, CPA
Chief Financial Officer
-
Andrew O
Chief Investor Relations Officer
-
Valerie Yeung, CPA
Finance Manager
-
Jay Vijayan, PhD
Chief Scientific Officer
-
Mary Shatzoff, MSc, RAC
Chief Regulatory Affairs Officer
-
Luis Rojas, MSc, PhD
Chief Biometrics and Clinical Development Officer
-
Luis Rojas-Graterol, MSc
Clinical Operations Manager
FHL Scientific Advisory Board
-
Kalipada Pahan, PhD
Professor, Neurological Sciences, Biochemistry & Pharmacology
-
Mitchel Berger, MD
Chair of Neurological Surgery at UCSF
-
Khalid Iqbal, PhD
Professor and Chairman of Neurochemistry at New York Institute for IBR
-
Han-Jun Kim, MD
Professor of Neurology at Seoul National University
-
Theron (Ted) Odlaug, PhD
Board Member, Ascendia Pharmaceuticals Inc. and Pharma Nobis, LLC.
FHL Board of Directors
-
Alex Yang, JD, LLM
Chief Executive Officer & Chair of the Board
-
Anthony Lam, CFA, CPA
Chief Financial Officer
-
Andrew O
Chief Investor Relations Officer